Study for the mechanism of hyperuricemia shaped by intestinal flora

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027696

Enrollment

Unknown

Registered

2019-11-23

Start date

2019-12-01

Completion date

Unknown

Last updated

2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperuricemia

Interventions

Hyperuricemia group:no

Normal control group:no

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with hyperuricemia; 2) Aged 20 to 60 years old; 3) Volunteers who signed informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with severe digestive tract and respiratory infections; 2) Individuals suffering from diseases such as hypertension, diabetes, and coronary heart disease; 3) Individuals with severe gastrointestinal diseases; 4) Individuals taking antibiotics, hormones, prebiotics and probiotics, which may affect the human intestinal flora, one month before enrollment.

Design outcomes

Primary

Measure	Time frame
Blood uric acid level;The structure and composition of gut microbiome;	—

Secondary

Measure	Time frame
blood pressure;BMI;Blood lipid level;Blood sugar level;Liver function level;Renal function level;HbA1c;	—

Countries

China

Contacts

Public ContactHong-Wei Zhou

Zhujiang Hospital, Southern Medical University

811807859@qq.com+86 18688489622

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026